Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma

NCT02313389 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

428

Enrollment

OTHER

Sponsor class

Conditions

Primary Central Nervous System Lymphoma

Interventions

DRUG: Rituximab, Methotrexate, Temozolomide

Sponsor

Assistance Publique - Hôpitaux de Paris